A detailed history of Walleye Trading LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Walleye Trading LLC holds 2,397,600 shares of SWTX stock, worth $113 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
2,397,600
Previous 1,161,200 106.48%
Holding current value
$113 Million
Previous $51.2 Million 119.86%
% of portfolio
0.21%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

SELL
$34.43 - $46.99 $1.66 Million - $2.27 Million
-48,323 Reduced 90.62%
5,000 $234,000
Q1 2025

May 14, 2025

BUY
$32.5 - $59.93 $1.73 Million - $3.2 Million
53,323 New
53,323 $2.35 Million
Q1 2024

May 15, 2024

BUY
$36.5 - $52.5 $54,494 - $78,382
1,493 New
1,493 $73,000
Q3 2023

Nov 14, 2023

BUY
$23.12 - $31.38 $190,555 - $258,633
8,242 New
8,242 $190,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.93B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.